Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

Share Price is delayed by 15 minutes
Get Live Data
2,730.00    -85.00 (-3.02%)
Bid:
2,695.00
Ask:
2,790.00
Spread: 95.00 (3.525%)
Market Cap: £1.29b
RHIM Live PriceLast checked at - London Stock Exchange

Intraday RHI Magnesita Share Chart

Director/PDMR Shareholding

28 Mar 2025 16:12

RNS Number : 7644C
RHI Magnesita N.V.
28 March 2025
 

RHI Magnesita N.V.

("RHI Magnesita" or the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

RHI Magnesita N.V. announces that on 25 March 2025, a person discharging managerial responsibilities ("PDMR") exercised share options over 58,755 ordinary shares, represented by depositary interests, of €1 each (the "Award") in the capital of the Company ("Ordinary Shares" or "Shares"). The Award, made under the terms of the Company's Long Term Incentive Plan ("LTIP"), was granted on 8 March 2022.

 

The Award vested on 17 March 2025, following the assessment of the performance conditions which are disclosed in the Remuneration Report on page 224 of the 2024 Annual Report, available on the Company's website at www.rhimagnesita.com.

 

Shares acquired on exercise must be retained until the fifth anniversary of the date of grant, being 8 March 2027, other than to pay related taxes. Shares are being sold to cover taxes and this is expected to conclude in the course of the forthcoming week. The Award is subject to clawback provisions as outlined in the LTIP rules, available on the Company's website.

 

To satisfy the exercise of these Awards, Shares are being transferred from the Company's treasury account and being sold in the market to cover taxes. No consideration is payable.

 

The PDMR exercised their Award as follows:

 

Director/PDMR

Position

Options exercised

Shares sold to cover personal tax liabilities

Stefan Borgas

Chief Executive Officer

58,755

9,464

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Stefan Borgas

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

RHI Magnesita N.V.

b)

 

LEI

 

724500UWG6A61XNA3Y36

 

National company register number: 68991665

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

RHI Magnesita NV - Ordinary shares

Identification code

Securities no.: 38785413, ISIN no.: NL0012650360

b)

 

Nature of the transaction

 

1. Exercise of an award granted on 8 March 2022 under the RHI Magnesita Long Term Incentive Plan ("LTIP")

2. Sales of shares to fund the tax liability due

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

58,755

2. £33.21

2,920

3. £33.13

3,559

4. £32.35

2,985

d)

 

Aggregated information

Aggregated volume

Aggregated Price

1. 58,755

Nil

2. 2,920

£96,973.2

3. 3,559

£ 117,909.67

4. 2,985

£ 96,564.8

- Aggregated volume

 9,464 shares sold

- Price

£311,448

e)

 

Date of the transaction

 

25 March 2025 to 27 March 2025

f)

 

Place of the transaction

 

London Stock Exchange - Main Market

 

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel: +43 699 1870 6490

Email: chris.bucknall@rhimagnesita.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLRVIITFIE
Date   Source Headline
1st Aug 20247:00 amRNSTotal Voting Rights
24th Jul 20247:00 amRNS2024 Half Year Results
12th Jul 20241:40 pmRNSNotice of Results
14th Jun 20247:00 amRNSNotification of major shareholding
6th Jun 20248:45 amRNSDirector/PDMR Shareholding
3rd Jun 20248:54 amRNSTotal Voting Rights
9th May 202412:11 pmRNSExercise of LTIP Options by PDMR
8th May 202410:03 amRNSDirector/PDMR Shareholding
3rd May 20244:12 pmRNSExercise of LTIP Options by PDMR
3rd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20243:56 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20249:27 amRNSTotal Voting Rights
2nd Apr 20241:16 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSAcquisition of Resco Group
21st Mar 20249:03 amRNSNotice of AGM
8th Mar 20249:29 amRNSDirector/PDMR Shareholding
28th Feb 202411:50 amRNS2023 Full Year Results
1st Feb 20247:46 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
1st Dec 20239:02 amRNSTotal Voting Rights
1st Dec 20238:39 amRNSNotification of major shareholding
31st Oct 20237:00 amRNSQ3 2023 Trading Update
16th Oct 20237:00 amRNSNotification of major shareholding
3rd Oct 20237:00 amRNSAcquisition of P-D Refractories
26th Sep 202311:00 amRNSDirector Nomination
1st Sep 20237:00 amRNSTotal Voting Rights
28th Jul 202310:55 amRNSNotification of major shareholding
27th Jul 20233:47 pmRNSNotification of major shareholding
26th Jul 20237:00 amRNSRHI Magnesita half-year results
19th Jul 20233:36 pmRNSNotice of Results
10th Jul 20235:31 pmRNSResponse to partial offer extension
3rd Jul 202311:48 amRNSTotal Voting Rights
27th Jun 20238:53 amRNSResponse to partial offer
19th Jun 20233:20 pmRNSNotification of major shareholding
16th Jun 20237:00 amRNSReplacement: Exercise of LTIP Options by PDMRs
16th Jun 20237:00 amRNSTotal Voting Rights
15th Jun 20237:00 amRNSTrading Update
31st May 20231:40 pmRNSExercise of LTIP Options by PDMRs
30th May 202311:04 amRNSResponse to intended partial cash offer
24th May 20234:10 pmRNSResult of AGM 2023
5th May 20237:00 amRNSQ1 2023 Trading Update
21st Apr 20234:11 pmRNSAcquisition of Seven Refractories
13th Apr 20237:00 amRNSDebt financing update
12th Apr 20237:00 amRNSRHI Magnesita - Notice of AGM 2023
5th Apr 20235:00 pmRNSIndian subsidiary equity issuance
29th Mar 20234:47 pmRNSIndian subsidiary equity issuance
29th Mar 20237:00 amRNSAcquisition of Dalmia GSB Refractories GmbH
6th Mar 20235:39 pmRNS2023 Long Term Incentive Plan Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.